AMN Healthcare Services Inc key statistics and ratios
In fiscal 2025, AMN Healthcare Services Inc had return on equity of -14.2%, an operating margin of -2.0%, debt equal to 120.7% of equity and a current ratio of 0.94. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 26.9% | 27.5% | 28.1% | 28.3% | 29.4% | 30.5% | 32.1% | 32.6% | 32.4% | 32.6% | 33.5% | 33.1% | 32.9% | 32.7% | 33.0% | 30.8% | 28.3% | 27.8% |
| Operating margin | −20.2% | −6.5% | 4.2% | 5.6% | 6.5% | 6.6% | 8.8% | 10.1% | 10.7% | 9.5% | 8.0% | 6.2% | 12.0% | 12.3% | 8.9% | −3.4% | −2.0% | 5.8% |
| Net margin | −16.1% | −7.8% | −3.0% | 1.8% | 3.3% | 3.2% | 5.6% | 5.6% | 6.7% | 6.6% | 5.1% | 3.0% | 8.2% | 8.5% | 5.6% | −4.9% | −3.5% | 3.1% |
| Free-cash-flow margin | 12.5% | 0.6% | 1.7% | 5.5% | 5.1% | 0.8% | 2.0% | 5.9% | 6.7% | 9.0% | 8.5% | 9.2% | 6.3% | 11.0% | 7.1% | 8.0% | 8.6% | 12.8% |
| Return on equity | −71.5% | −32.1% | −18.2% | 10.8% | 16.5% | 14.0% | 27.1% | 26.6% | 26.2% | 23.6% | 16.6% | 9.1% | 33.0% | 40.3% | 22.5% | −19.1% | −14.2% | 15.2% |
| Return on assets | — | −9.2% | −4.8% | 3.3% | 5.9% | 5.2% | 10.5% | 10.2% | 10.9% | 10.3% | 6.7% | 3.3% | 11.9% | 14.8% | 7.2% | −5.5% | −4.2% | 4.7% |
| Asset turnover | — | 1.19 | 1.62 | 1.81 | 1.80 | 1.61 | 1.87 | 1.84 | 1.63 | 1.56 | 1.30 | 1.12 | 1.45 | 1.74 | 1.30 | 1.12 | 1.21 | 1.54 |
| Current ratio | — | 1.52 | 1.52 | 1.86 | 1.63 | 1.59 | 1.50 | 1.64 | 1.79 | 1.57 | 1.48 | 1.26 | 1.39 | 1.27 | 1.28 | 1.09 | 0.94 | 1.13 |
| Debt to equity | 0.0% | 139.9% | 172.1% | 87.6% | 73.3% | 63.3% | 63.1% | 82.1% | 57.8% | 69.6% | 84.8% | 106.4% | 73.1% | 81.4% | 157.6% | 150.0% | 120.7% | 100.2% |
| Interest cover (operating income ÷ interest) | n/m | n/m | 1.6x | 2.1x | 6.8x | 7.4x | 16.5x | 12.4x | 10.8x | 12.6x | 6.2x | 2.6x | 14.0x | 16.0x | 6.3x | n/m | n/m | 5.6x |
| Effective tax rate | — | — | 64.0% | 40.3% | 41.0% | 43.4% | 32.4% | 39.9% | 31.2% | 24.1% | 23.2% | 22.8% | 26.3% | 26.8% | 25.9% | — | — | 36.1% |
| SG&A as % of revenue | 20.7% | 24.3% | 22.0% | 21.3% | 21.6% | 22.4% | 21.8% | 20.9% | 20.1% | 21.2% | 22.9% | 23.0% | 18.3% | 17.9% | 19.8% | 21.2% | 21.7% | 19.1% |
| Capital spending as % of revenue | 0.5% | 0.6% | 0.5% | 0.6% | 0.9% | 1.8% | 1.8% | 1.2% | 1.3% | 1.6% | 1.6% | 1.6% | 1.3% | 1.4% | 2.7% | 2.7% | 1.3% | 0.9% |
| Free cash flow ÷ net income | — | — | — | 308.8% | 155.2% | 25.7% | 35.8% | 105.8% | 101.1% | 135.3% | 166.4% | 310.1% | 76.9% | 130.1% | 127.4% | — | — | 418.5% |
| Dividends and buybacks ÷ free cash flow | — | — | — | — | — | 0.0% | 0.0% | 11.8% | 15.0% | 34.9% | 9.9% | 0.0% | 1.1% | 99.8% | 158.2% | 0.0% | 0.0% | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 31.0% | 29.8% | 28.7% | 29.8% | 29.1% | 26.1% | 26.8% | 30.6% |
| Operating margin | 3.2% | −27.6% | 1.8% | −18.8% | 7.5% | 1.1% | 8.5% | 4.0% |
| Net margin | 1.0% | −25.5% | −0.2% | −17.7% | 4.6% | −1.0% | 4.5% | 3.1% |
| Free-cash-flow margin | 6.9% | 7.7% | 12.0% | 10.4% | 2.3% | 9.0% | 40.3% | −29.5% |
| Current ratio | 1.18 | 1.09 | 1.08 | 1.00 | 1.05 | 0.94 | 1.09 | 1.13 |
| Debt to equity | 94.9% | 149.4% | 118.3% | 139.3% | 131.4% | 119.5% | 104.2% | 100.2% |
| SG&A as % of revenue | 21.8% | 21.6% | 21.4% | 23.5% | 21.8% | 20.3% | 15.8% | 21.9% |
Financial health
- Short-term assets cover short-term liabilities $869m of assets due within a year against $770m of liabilities due within a year.
- Short-term assets cover long-term liabilities $869m short-term assets against $852m of longer-dated liabilities.
- More cash than debt $362m of cash against $743m of debt.
- Debt below 40% of shareholders' equity Debt is 100% of equity.
- Debt burden no higher than five years ago Debt to equity moved from 72% to 100% over five years.
- A year's operating cash flow covers at least 20% of debt $471m of operating cash flow against $743m of debt.
- Operating profit covers interest at least five times over Operating income of $200m against $36m of interest.
Moat
Moderate moat
How hard AMN Healthcare Services's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 20 / 20
Cash operating profit has been a median 14.6% of total assets over 10 years.
- Pricing power 12 / 20
Gross margin has been a median 32.6%, moving by 1.7 percentage points (standard deviation) across 10 years.
- Durability 2 / 20
Operating margin has been a median 9.1%; its worst year was -10.5%.
- Cash conversion 14 / 20
Free cash flow was positive in 10 of 10 years, at a median 8.8% of revenue.
- Discipline 20 / 20
The diluted share count fell 18.4% over five years; stock-based pay has been a median 0.6% of revenue.
AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (67 before it).
Compare with peers
- Astrana Health, Inc. statistics
- Chemed Corp statistics
- Aveanna Healthcare Holdings, Inc. statistics
- Hims & Hers Health, Inc. statistics
- Privia Health Group, Inc. statistics
Head to head: AMN vs ASTHAMN vs CHEAMN vs AVAH
More: Health Care Services stocks compared, Health Care sector, rankings of US companies